Fluarix: all 21 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCPCompletedNCT03722589Phase 4Results posted
- Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™CompletedNCT01196026Phase 4Results posted
- Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTMCompletedNCT01190215Phase 4Results posted
- Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in ElderlyCompletedNCT00968890Phase 2Results posted
- Influenza Vaccine in Pregnant WomenCompletedNCT00905125Phase 2Results posted
- Immune Responses Induced by Different Licensed Influenza VaccinesCompletedNCT00902278Not applicableResults posted
- Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in ChildrenCompletedNCT00764790Phase 3Results posted
- Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.CompletedNCT00750360Phase 4Results posted
- A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in AdultsCompletedNCT00706563Phase 3Results posted
- Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old AdultsCompletedNCT00453986Phase 3Results posted
- Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in AdultsCompletedNCT00385255Phase 3Results posted
- Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in ChildrenCompletedNCT00383123Phase 3Results posted
- Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™CompletedNCT00377611Phase 4Results posted
- Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly PopulationCompletedNCT00318149Phase 2Results posted
- A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu VaccinesCompletedNCT00558649Not applicable
- Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) StatusCompletedNCT00442975Phase 4
- Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly AdultsCompletedNCT00386698Phase 2
- Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older AdultsCompletedNCT00380211Phase 3
- Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult PopulationCompletedNCT00377585Phase 2
- Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or AboveCompletedNCT00345904Phase 3
- Fluarix Immunogenicity and Safety TrialCompletedNCT00100399Phase 3